$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

초록
AI-Helper 아이콘AI-Helper

근막통증은 발통점에 의해 야기되는 근육통을 특징으로 하는 전반적인 통증 증후군으로 정의될 수 있다. 근막통증은 경부통, 견통, 두통 및 구강안면통증이 지속적으로 존재할 수 있는 흔한 원인이 될 수 있다. 구강안면통증을 치료하는 의사들은 근막통증이 구강안면통증에 기여하는 바에 대하여 이해하고 있어야 한다. 본 증례는 보툴리눔 톡신 A형을 이용한 만성 근막통증의 성공적인 치료에 대하여 보고하고자 한다.

Abstract AI-Helper 아이콘AI-Helper

MyoFascial Pain Syndrome(MFPS) is defined as a regional pain syndrome characterized by muscle pain caused by myofascial trigger points (MTrPs). Myofascial pain is a common cause of persistent regional pain such as neck pain, shoulder pain, headaches, and orofacial pain. Clinicians who deal with orof...

주제어

AI 본문요약
AI-Helper 아이콘 AI-Helper

* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.

제안 방법

  • (Fig. 3) She did not visit our clinic for 5 months, then there were a 4th, 5th, and 6th injection at the same site. Figure 4 shows the pain intensity.

대상 데이터

  • A 31-year-old female patient visited the Department of Oral Diagnosis and Oral Medicine in the Chosun University, Dental Hospital, Gwang-ju, Korea, with a chief complaint of continuous pain in the both temporomandibular joint(TMJ) on May 10, 2006. The patient also complained of headache (bilateral temporal area) and shoulder pain.
본문요약 정보가 도움이 되었나요?

참고문헌 (36)

  1. Hong CZ, Simons DG. Pathophysiologic and electrophysiologic mechanism of myofascial trigger points. Arch Phys Med Rehabil 1998;79:863-872. 

  2. Simons DG, Travell JG, Simons LS. Travell & Simons's Myofascial Pain and Dysfunction: The Trigger Point Manual. 2nd edi., Baltimore, 1999,Williams & Wilkins, pp. 11-86. 

  3. Fleckenstein J, Zaps D, Ruger LJ, et al. Discrepency between prevalence and perceived effectiveness of treatment methods in myofascial pain syndrome: Results of a cross-sectional, nationwide survey. BMC Musculoskelet Disord 2010;11:32-41. 

  4. Svensson P, List T, Hector G. Analysis of stimulusevoked pain in patients with myofascial temporomandibular pain disorders. Pain 2001;92:399-409. 

  5. Fricton JR, Kroening R, Haley D, Siegert R. Myofascial pain syndrome of the head and neck: a review of clinical characteristics of 164 patients. Oral Surg Oral Med Oral Pathol 1985;60:615-623. 

  6. Fricton JR. Myofascial pain: clinical characteristics and diagnostic criteria. J Musculoskel Pain 1993;1: 37-47. 

  7. Han SC, Harrison P. Myofascial pain syndrome and triggerpoint management. Reg Anesth 1997;22:89-101. 

  8. Stohler CS. Masticatory myalgias. In Oral and Maxillofacial Surgery. Temporomandibular Disorders. Philadelphia, 2000, WB Saunders, pp.38 - 45. 

  9. Piovesan EJ, Werneck LC, Teive HA, et al. Neurophysiology of pain in tentorial irritation: description of a case secondary to medulloblastoma. Arq Neuropsiquiatr 1998;56:677-682. 

  10. Hutchinson PJ, Pickard JD, Higgins JN. Vertebral artery dissection presenting as cerebellar infarction. J Neurol Neurosurg Psychiatry 2000;68:98?99. 

  11. Aoki KR. Review of a proposed mechanisms for the antinociceptive action of botulinum toxin type A. NeuroToxicology 2005;26:785 - 793. 

  12. Rand J, Whaler BC. Impairment of sympathetic transmission by Botulinum toxin. Nature 1965;206:588 - 591. 

  13. Filippi GM, Errico P, Santarelli R, Bagolini B, Manni E. Botulinum A toxin effects on rat jawmuscle spindles. Acta Otolaryngol 1993;113:400 - 404. 

  14. Jankovic J, Tintner R. Botulinum toxin for the treatment of cervical dystonia. Expert Opinion 2001;2:1985 - 1994. 

  15. Babcock MS, Foster L, Pasquina P, Jabbari B. Treatment of pain attributed to plantar fasciitis with Botulinum toxin A: A short-term, randomized, placebo-controlled, double-blind study. Am J Phys Med Rehabil 2005;84:649 - 654. 

  16. Abbott JA, Jarvis SK, Lyons SD, Thompson A, Vancaille TG. Botulinum toxin type A for chronic pain and pelvic floor spasm in women: A randomized controlled trial. Obstet Gynecol 2006;108:915 - 923. 

  17. Silberstein S, Mathew N, Saper J, Jenkins S. Botulinum toxin type A as a migraine preventive treatment. For the BOTOX Migraine Clinical Research group. Headache 2000;40:445 - 450. 

  18. Foster L, Clapp L, Erickson M, Jabbari B. Botulinum toxin A and chronic low back pain. Neurology 2001;56:1290 - 1293. 

  19. Steinder A. The interpretation of the sciatic radiation and the syndrome of low back pain. J Bone Joint Surg 1940;22:28-34. 

  20. Graff-Radford SB. Regional myofascial pain syndrome and headache: principles of diagnosis and management. Curr Pain Headache Rep 2001;5(4): 376-381. 

  21. Travell JG, Simons DG. Myofascial Pain and Dysfunction: The Trigger Point Manual. Baltimore, 1983, Williams and Wilkins, pp 24-25. 

  22. Graff-Radford SB. Myofascial pain: diagnosis and management. Curr Pain Headache Rep 2004;8: 463-467. 

  23. Fricton JR, Kroening R, Haley D, Siegert R. Myofascial pain syndrome of the head and neck: a review of clinical characteristics of 164 patients. Oral Surg Oral Med Oral Pathol 1985;60:615 - 623. 

  24. Majlesi J, Unalan H. Effect of treatment on trigger points. Curr Pain Headache Rep 2010;14(5):353-360. 

  25. Sharav Y, Singer E, Schmidt E, et al.: The analgesic effect of amitriptyline on severe facial pain. Pain 1987;31:199-203. 

  26. Tsuga K, Akagawa Y, Sakaguchi R, Tsuru H. A short-term evaluation of the effectiviness of stabilisation therapy for specific symptoms of temporomandibular joint dysfunction syndrome. J Prosthet Dent 1989;61:610-613. 

  27. Gray RJM, Davies SJ, Quale AA. A comparison of two splints in the treatment of TMJ myofascial pain: can occlusal analysis be used to predict success of splint therapy? Br Dent J 1991;170:257-261. 

  28. Davies SJ, Gray RJM. The pattern of splint usage in the management of two common temporomandibular disorders. Part III: Long-term follow-up in an assessment of splint therapy in the management of disc displacement with reduction and pain dysfunction syndrome. Br Dent J 1997;183:279-283. 

  29. Al-Ani Z, Gray RJ, Davies SJ, Sloan P, Glenny AM. Stabilization splint therapy for the treatment of temporomandibular myofascial pain: a systematic review. J Dent Educ 2005;69(11):1242-1250. 

  30. Brin MF, Fahn S, Moskowitz C, et al. Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm. Adv Neurol 1988;50:599 - 608. 

  31. Tarsy D, First ER. Painful cervical dystonia: clinical features and response to treatment with botulinum toxin. Mov Disord 1999;14:1043 - 1045. 

  32. Qerama E, Fuglsang-Frederiksen A, Jensen TS. The role of botulinum toxin in management of pain: an evidence-based review. Curr Opin Anaesthesiol 2010; 23(5):602-610. 

  33. Kerr FW. A mechanism to account for frontal headache in cases of posterior fosse tumors. J Neurosurg 1961;18:605-609. 

  34. Piovesan EJ, Werneck LC, Teive HA, et al. Neurophysiology of pain in tentorial irritation: description of a case secondary to medulloblastoma. Arq Neuropsiquiatr 1998;56:677-682. 

  35. utchinson PJ, Pickard JD, Higgins JN: Vertebral artery dissection presenting as cerebellar infarction. J Neurol Neurosurg Psychiatry 2000;68:98-99. 

  36. Piovesan EJ, Kowacs PA, Oshinsky ML. Convergence of cervical and trigeminal sensory afferents. Curr Pain Headache Rep 2003;7(5):377-83. 

저자의 다른 논문 :

관련 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로